Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Daiichi Sankyo
Cipla
Mallinckrodt
Medtronic
Accenture
QuintilesIMS
Citi
McKinsey

Generated: October 18, 2017

DrugPatentWatch Database Preview

MONISTAT 1 COMBINATION PACK Drug Profile

« Back to Dashboard

Which patents cover Monistat 1 Combination Pack, and what generic Monistat 1 Combination Pack alternatives are available?

Monistat 1 Combination Pack is a drug marketed by Medtech Products and is included in one NDA. There is one patent protecting this drug.

This drug has fourteen patent family members in twelve countries.

The generic ingredient in MONISTAT 1 COMBINATION PACK is miconazole nitrate. There are twenty-eight drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the miconazole nitrate profile page.

Summary for Tradename: MONISTAT 1 COMBINATION PACK

US Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list65
Clinical Trials: see list21,691
Patent Applications: see list1,445
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MONISTAT 1 COMBINATION PACK at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medtech Products
MONISTAT 1 COMBINATION PACK
miconazole nitrate
CREAM, SUPPOSITORY;TOPICAL, VAGINAL021308-001Jun 29, 2001OTCYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: MONISTAT 1 COMBINATION PACK

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medtech Products
MONISTAT 1 COMBINATION PACK
miconazole nitrate
CREAM, SUPPOSITORY;TOPICAL, VAGINAL021308-001Jun 29, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Premature patent expiration for: MONISTAT 1 COMBINATION PACK

Expiration due to failure to pay maintenance fee

Patent Number Tradename Expiration Date
► Subscribe
MONISTAT 1 COMBINATION PACK
► Subscribe

International Patent Family for Tradename: MONISTAT 1 COMBINATION PACK

Country Document Number Estimated Expiration
Australia2024800► Subscribe
Japan2002530327► Subscribe
World Intellectual Property Organization (WIPO)0030626► Subscribe
Brazil9907150► Subscribe
Argentina021863► Subscribe
Spain2262353► Subscribe
China1332663► Subscribe
Germany69930725► Subscribe
Canada2318125► Subscribe
Australia777508► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Mallinckrodt
McKesson
Baxter
UBS
Moodys
Federal Trade Commission
Cerilliant
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot